Role of Oxidized LDL and Antioxidants in Atherosclerosis
Reference28 articles.
1. Björkhem, I., Henrikkson-Freyschuss, A., Breuer, O., Diczfalusy, U., Berglund, L., and Henriksson, P., 1991, The antioxidant butylated hydroxytoluene protects against atherosclerosis, Arterioscler. Thromb. 11:15–22. 2. Brown, M.S. and Goldstein, J.L., 1983, Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis, Ann. Rev. Biochem. 52:223–261. 3. Carew, T., Schwenke, D.C., and Steinberg, D., 1987, Antiatherogenic effect of probucol unrelated to it hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low-density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit, Proc. Natl. Acad. Sci. USA. 84:7725–7729. 4. Daugherty, A., Zweifel, B.S., and Schonfeld, G., 1989, Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbit, Br. J. Pharmacol. 98:612–618. 5. Davies, P.F., Reidy, M.A., Goode, T.B., and Bowyer, D.E., 1971, Scanning electron microscopy in the evaluation of endothelial integrity of the fatty lesion in atherosclerosis, Atheroscler. 25:125–130.
Cited by
131 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|